« United Kingdom Office of Fair Trading: Accuses GlaxoSmithKline for Pay for Delay | Main | Physician Payment Sunshine Act: Washington Legal Foundation Comments Question the Constitutionality of Reporting for Reprints and Textbooks »

May 17, 2013

TrackBack

TrackBack URL for this entry:
http://www.typepad.com/services/trackback/6a00e5520572bb883401901be9dbbe970b

Listed below are links to weblogs that reference Proposed FDA Guidance on Financial Disclosure and the Physician Payment Sunshine Regulations – Divergent Paths and Duplicated Efforts:

Comments

Feed You can follow this conversation by subscribing to the comment feed for this post.

The comments to this entry are closed.

Sponsors

Enter your Email:
Preview | Powered by FeedBlitz

August 2014

Sun Mon Tue Wed Thu Fri Sat
          1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30
31